Concurrently, BA-FXR signaling promotes Tregs differentiation while suppressing CTL activity via upregulation of immune checkpoints (PD-1/CTLA-4) in HCC murine models [126, 127]. The gene discussed is PDCD1; the disease is hepatocellular carcinoma.